MNI China Daily Summary: Tuesday, Feb 4

MNI BRIEF: EC Head Confirms Nat'l Escape Clause Activation

MNI BRIEF: China To Work With Partners As U.S. Tariffs Hit

MNI China Press Digest March 4: PBOC, U.S., FDI

MNI: PBOC Net Drains CNY280.3 Bln via OMO Tuesday

MNI: PBOC Sets Yuan Parity Lower At 7.1739 Tues; -1.30% Y/Y

MNI: EUROZONE JAN UNEMPLOYMENT RATE 6.2%

MNI:AUSTRALIA Q4 CURR ACCT BALANCE -12547M

MNI: AUSTRALIA JAN RETAIL SALES +0.3% M/M

GERMANY: Official Interim Election Results Tilt Towards Missing BSW & FDP

GERMANY: Economy Ministry Lowers 2025 Growth Forecast As Expected

© 1982-2025 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

HEALTHCARE: Healthcare: Week in Review

HEALTHCARE
USCredit BulletsCEEMEAEurozoneGermanyFranceBulletUKNorth America
  • A very strong week for Eurofins.  FY25 Objectives stated an intention to “achieve self-financing of all its needs” which we read as meaning that they would not issue this year. The curve was uniformly tighter by 12bps.
  • Smith & Nephew is a single ISIN issuer in EUR so can move on more on technicals. Stryker had good numbers 2 weeks ago as surgery recovers from Covid. Some of this may be spilling over into SNLN. The other factor to consider is break-up talk which is never very far away.  Earnings 25th Feb.
  • Bureau Veritas also reports on 25th. The equity reached an all-time high today. The company called of SGS merger talks on 27th Jan. BVIFP 3.5 36 is leading with an 8bps tightening in 2 days; the move higher in bund yields on the 12th may have helped.
  • Fresenius Medical equity dropped on Friday following reduced guidance from DaVita. DVA and FMEGR control 2/3 of the US Dialysis market.  Bonds were unaffected. Results 25th.  
Healthcare
164 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.
  • A very strong week for Eurofins.  FY25 Objectives stated an intention to “achieve self-financing of all its needs” which we read as meaning that they would not issue this year. The curve was uniformly tighter by 12bps.
  • Smith & Nephew is a single ISIN issuer in EUR so can move on more on technicals. Stryker had good numbers 2 weeks ago as surgery recovers from Covid. Some of this may be spilling over into SNLN. The other factor to consider is break-up talk which is never very far away.  Earnings 25th Feb.
  • Bureau Veritas also reports on 25th. The equity reached an all-time high today. The company called of SGS merger talks on 27th Jan. BVIFP 3.5 36 is leading with an 8bps tightening in 2 days; the move higher in bund yields on the 12th may have helped.
  • Fresenius Medical equity dropped on Friday following reduced guidance from DaVita. DVA and FMEGR control 2/3 of the US Dialysis market.  Bonds were unaffected. Results 25th.  
Healthcare